Virtually-induced threat in Parkinson's: Dopaminergic interactions between anxiety and sensory-perceptual processing while walking
- PMID: 26004056
- DOI: 10.1016/j.neuropsychologia.2015.05.015
Virtually-induced threat in Parkinson's: Dopaminergic interactions between anxiety and sensory-perceptual processing while walking
Abstract
Research evidence has suggested that anxiety influences gait in PD, with an identified dopa-sensitive gait response in highly anxious PD. It has been well-established that accurate perception of the environment and sensory feedback is essential for gait. Arguably since sensory and perceptual deficits have been noted in PD, anxiety has the potential to exacerbate movement impairments, since one might expect that reducing resources needed to overcome or compensate for sensory-perceptual deficits may lead to even more severe gait impairments. It is possible that anxiety in threatening situations might consume more processing resources, limiting the ability to process information about the environment or one's own movement (sensory feedback) especially in highly anxious PD. Therefore, the current study aimed to (i) evaluate whether processing of threat-related aspects of the environment was influenced by anxiety, (ii) evaluate whether anxiety influences the ability to utilize sensory feedback in PD while walking in threatening situations, and (iii) further understand the role of dopaminergic medication on these processes in threatening situations in PD. Forty-eight participants (24 HC; 12 Low Anxious [LA-PD], 12 Highly Anxious [HA-PD]) completed 20 walking trials in virtual reality across a plank that was (i) located on the ground (GROUND) (ii) located above a deep pit (ELEVATED); while provided with or without visual feedback about their lower limbs (+VF; -VF). After walking across the plank, participants were asked to judge the width of the plank they had just walked across. The plank varied in size from 60-100 cm. Both ON and OFF dopaminergic medication states were evaluated in PD. Gait parameters, judgment error and self-reported anxiety levels were measured. Results showed that HA-PD reported greater levels of anxiety overall (p<0.001) compared to HC and LA-PD, and all participants reported greater anxiety during the ELEVATED condition compared to GROUND (p=0.01). PD had similar judgment error as HC. Additionally, medication state did not significantly influence judgment error in PD. More importantly, HA-PD were the only group that did not adjust their step width when feedback was provided during the GROUND condition. However, medication facilitated a reduction in ST-CV when visual feedback was available only in the HA-PD group. Therefore, the current study provides evidence that anxiety may interfere with information processing, especially utilizing sensory feedback while walking. Dopaminergic medication appears to improve utilization of sensory feedback in stressful situations by reducing anxiety and/or improving resource allocation especially in those with PD who are highly anxious.
Keywords: Anxiety; Dopaminergic replacement therapy; Parkinson's disease; Perception; Sensory feedback; Virtual reality.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Anxiety-provoked gait changes are selectively dopa-responsive in Parkinson's disease.Eur J Neurosci. 2015 Aug;42(4):2028-35. doi: 10.1111/ejn.12928. Epub 2015 May 23. Eur J Neurosci. 2015. PMID: 25899750 Clinical Trial.
-
Does manipulating the speed of visual flow in virtual reality change distance estimation while walking in Parkinson's disease?Exp Brain Res. 2015 Mar;233(3):787-95. doi: 10.1007/s00221-014-4154-z. Epub 2014 Dec 2. Exp Brain Res. 2015. PMID: 25450453
-
Anxiety provokes balance deficits that are selectively dopa-responsive in Parkinson's disease.Neuroscience. 2017 Jan 6;340:436-444. doi: 10.1016/j.neuroscience.2016.11.011. Epub 2016 Nov 14. Neuroscience. 2017. PMID: 27856344
-
Anxiety in Parkinson's Disease: A Systematic Review of Neuroimaging Studies.J Neuropsychiatry Clin Neurosci. 2021 Fall;33(4):280-294. doi: 10.1176/appi.neuropsych.20110272. Epub 2021 Jul 19. J Neuropsychiatry Clin Neurosci. 2021. PMID: 34280319
-
Neuropsychological and perceptual defects in Parkinson's disease.Parkinsonism Relat Disord. 2003 Aug;9 Suppl 2:S83-9. doi: 10.1016/s1353-8020(03)00022-1. Parkinsonism Relat Disord. 2003. PMID: 12915072 Review.
Cited by
-
Future Therapeutic Strategies for Freezing of Gait in Parkinson's Disease.Front Hum Neurosci. 2021 Nov 2;15:741918. doi: 10.3389/fnhum.2021.741918. eCollection 2021. Front Hum Neurosci. 2021. PMID: 34795568 Free PMC article. Review.
-
Investigating Therapies for Freezing of Gait Targeting the Cognitive, Limbic, and Sensorimotor Domains.Neurorehabil Neural Repair. 2021 Mar;35(3):290-299. doi: 10.1177/1545968321992331. Epub 2021 Feb 9. Neurorehabil Neural Repair. 2021. PMID: 33559531 Free PMC article. Clinical Trial.
-
Walking in fully immersive virtual environments: an evaluation of potential adverse effects in older adults and individuals with Parkinson's disease.J Neuroeng Rehabil. 2017 Feb 21;14(1):16. doi: 10.1186/s12984-017-0225-2. J Neuroeng Rehabil. 2017. PMID: 28222783 Free PMC article. Clinical Trial.
-
Decision making in Parkinson's disease: An analysis of the studies using the Iowa Gambling Task.Eur J Neurosci. 2021 Nov;54(10):7513-7549. doi: 10.1111/ejn.15497. Epub 2021 Nov 9. Eur J Neurosci. 2021. PMID: 34655122 Free PMC article. Review.
-
The impact of anxiety on gait impairments in Parkinson's disease: insights from sensor-based gait analysis.J Neuroeng Rehabil. 2024 Apr 30;21(1):68. doi: 10.1186/s12984-024-01364-3. J Neuroeng Rehabil. 2024. PMID: 38689288 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous